Earnings History Data for Neoleukin Therapeutics, Inc. (NLTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics Inc. is a biopharmaceutical company. It is engaged in creating next generation immunotherapies using de novo protein design technology. The company's product candidate consists of NL-201 which is in clinical stage. Neoleukin Therapeutics Inc., formerly known as Aquinox Pharmaceuticals Inc., is based in Seattle, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2022 | PM | NLTX | Neoleukin Therapeutics | 22.00 | -0.24 | -0.32 | 0.00 | Neoleukin Therapeutics GAAP EPS of -$0.24 beats by $0.07 [11/15/2022 6:24 AM] |
0.4210 | -0.11 (-20.58%) |
0.45 | -0.08 (-15.77%) |
0.41 - 6.34 | 643,474 | 290,000 | 41,544 | ||
| 09-08-2022 | AH | 4:05 PM ET (Aug 9) |
NLTX | Neoleukin Therapeutics, Inc. | 50.15 | -0.28 | -0.30 | -0.27 | Neoleukin Therapeutics GAAP EPS of -$0.28 beats by $0.02 [8/9/2022 4:33 PM] |
0.98 | 0.0 (0.45%) |
1.05 | 0.07 (7.63%) |
0.80 - 8.48 | 265,611 | 180,000 | 160 | |
| 09-05-2022 | AH | 4:00 PM ET (May 9) |
NLTX | Neoleukin Therapeutics | 56.00 | -0.28 | -0.30 | 0.00 | Neoleukin Therapeutics GAAP EPS of -$0.28 beats by $0.02 [5/9/2022 5:19 PM] |
1.17 | 0.03 (2.63%) |
1.21 | 0.07 (6.14%) |
1.12 - 11.73 | 798,465 | 264,205 | 450 | |
| 01-03-2022 | AH | 4:05 PM ET (Mar 1) |
NLTX | Neoleukin Therapeutics, Inc. | 114.56 | -0.28 | -0.30 | -0.24 | 2.71 | 0.17 (6.69%) |
2.54 | 0.0 (0.00%) |
2.45 - 13.40 | 249,651 | 150,000 | 611 | ||
| 04-11-2021 | AH | 4:05 PM ET (Nov 4) |
NLTX | Neoleukin Therapeutics | 312.00 | -0.28 | -0.28 | 0.00 | Neoleukin Therapeutics EPS in-line [11/4/2021 4:54 PM] |
7.70 | 0.26 (3.49%) |
7.32 | -0.12 (-1.61%) |
5.95 - 17.95 | 149,459 | 120,000 | 1,144 | |
| 05-08-2021 | AH | After the close (Aug 5) |
NLTX | Neoleukin Therapeutics, Inc. | 288.00 | -0.27 | -0.27 | 0.00 | Neoleukin Therapeutics EPS in-line [8/5/2021 5:06 PM] |
6.98 | -0.52 (-6.93%) |
7.75 | 0.25 (3.33%) |
6.55 - 17.95 | 139,645 | 240,000 | 3,246 | |
| 12-05-2021 | PM | NLTX | Neoleukin Therapeutics, Inc. | 490.14 | -0.27 | -0.24 | -0.18 | Neoleukin Therapeutics EPS misses by $0.04 [5/12/2021 8:21 AM] |
10.68 | -0.72 (-6.32%) |
11.40 | 0.0 (0.00%) |
9.63 - 18.13 | 151,509 | 150,000 | 2,665 | ||
| 25-03-2021 | AH | 4:00 PM ET (Mar 25) |
NLTX | Neoleukin Therapeutics, Inc. | 512.02 | -0.24 | -0.21 | -0.23 | Neoleukin Therapeutics EPS beats by $0.07 [3/25/2021 4:01 PM] |
11.81 | 0.13 (1.11%) |
11.68 | 0.0 (0.00%) |
9.12 - 18.13 | 177,457 | 320,000 | 9,958 | |
|
||||||||||||||||||
| 12-08-2020 | AH | 4:00 PM ET (Aug 12) |
NLTX | Neoleukin Therapeutics, Inc. | 461.82 | -0.20 | -0.19 | 0.00 | Neoleukin Therapeutics EPS misses by $0.04 [8/12/2020 4:04 PM] |
11.95 | -0.04 (-0.33%) |
12.17 | 0.18 (1.50%) |
2.53 - 18.13 | 235,037 | 262,580 | 233 | |
|
|
||||||||||||||||||